In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients

被引:0
|
作者
Tomasz Olszak
Paulina Zarnowiec
Wieslaw Kaca
Katarzyna Danis-Wlodarczyk
Daria Augustyniak
Pavel Drevinek
Anthony de Soyza
Siobhán McClean
Zuzanna Drulis-Kawa
机构
[1] University of Wroclaw,Institute of Genetics and Microbiology
[2] The Jan Kochanowski University,Division of Gene Technology
[3] Catholic University of Leuven,Department of Medical Microbiology, University Hospital Motol and 2nd Faculty of Medicine
[4] Charles University,Institute of Cellular Medicine, Medical School
[5] Newcastle University,Centre of Microbial Host Interactions
[6] Institute of Technology Tallaght,undefined
来源
关键词
bacteriophages; Phage treatment; Cystic fibrosis; model;
D O I
暂无
中图分类号
学科分类号
摘要
The goal of the study was to determine the relationship between in vitro/in vivo efficacy of environmental Pseudomonas phages and certain phenotypical properties of Pseudomonas aeruginosa (PA) strains. We studied the diversity between particular isolates and determined phage sensitivity in vitro and in vivo in the Galleria mellonella insect model. Twenty-eight lytic bacteriophages specific for PA were tested against 121 CF PA isolates including 29 mucoid PA strains. Most strains from cystic fibrosis (CF) patients were lysed by at least three phages (93.6 %), but completely insensitive strains were also present (6.4 %). Two phages PA5oct and KT28 exhibited high rates of lytic potency on 55–68 % of PA strains (72–86 % of mucoid isolates). We further explored phage activity against six PA strains (CF and non-CF) in vitro, comparing clonal differences in phage susceptibility with bacterial properties such as the ability to form biofilms, mucosity, twitching motility, and biochemical profiles. We observed the relationship between variation in phage susceptibility and Fourier transform infrared spectroscopy (FTIR) analysis in the spectra window of carbohydrates. The protective efficacy of two selected phages against PA PAO1 and 0038 infection was confirmed in vivo in G. mellonella larvae. Generally, the wax moth model results confirmed the data from in vitro assays, but in massive infection of CF isolates, the application of lytic phages probably led to the release of toxic compound causing an increase in larvae mortality. We assumed that apart of in vitro phage activity testing, a simple and convenient wax moth larvae model should be applied for the evaluation of in vivo effectiveness of particular phage preparations.
引用
收藏
页码:6021 / 6033
页数:12
相关论文
共 50 条
  • [31] Molecular typification of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.
    Iglesias, N. G.
    Marengo, J. M.
    Renteria, F.
    Gatti, B.
    Segal, E.
    Semorile, L.
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2008, 40 (01): : 3 - 8
  • [32] Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro
    Antos, M
    Trafny, EA
    Grzybowski, J
    PHARMACOLOGICAL RESEARCH, 1995, 32 (1-2) : 85 - 87
  • [33] Enzyme polymorphism in Pseudomonas aeruginosa strains recovered from cystic fibrosis patients in France
    Martin, C
    Boyd, EF
    Quentin, R
    Massicot, P
    Selander, RK
    MICROBIOLOGY-UK, 1999, 145 : 2587 - 2594
  • [34] Analysis of Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis Revealed Novel Groups of Filamentous Bacteriophages
    Evseev, Peter
    Bocharova, Julia
    Shagin, Dmitriy
    Chebotar, Igor
    VIRUSES-BASEL, 2023, 15 (11):
  • [35] In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    Li, J
    Turnidge, J
    Milne, R
    Nation, RL
    Coulthard, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 781 - 785
  • [36] Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains
    Di Bonaventura, Giovanni
    Lupetti, Veronica
    De Fabritiis, Simone
    Piccirilli, Alessandra
    Porreca, Annamaria
    Di Nicola, Marta
    Pompilio, Arianna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [37] Antibacterial and Antibiofilm Effects of Lactobacilli Strains against Clinical Isolates of Pseudomonas aeruginosa under Conditions Relevant to Cystic Fibrosis
    Batoni, Giovanna
    Catelli, Elisa
    Kaya, Esinguel
    Pompilio, Arianna
    Bianchi, Marta
    Ghelardi, Emilia
    Di Bonaventura, Giovanni
    Esin, Semih
    Maisetta, Giuseppantonio
    ANTIBIOTICS-BASEL, 2023, 12 (07):
  • [38] Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients
    Hana Rac
    Kayla R. Stover
    Jamie L. Wagner
    S. Travis King
    Henderson D. Warnock
    Katie E. Barber
    Infectious Diseases and Therapy, 2017, 6 : 507 - 513
  • [39] Novel Bacteriophages Show Activity against Selected Australian Clinical Strains of Pseudomonas aeruginosa
    Namonyo, Samuel
    Carvalho, Gilda
    Guo, Jianhua
    Weynberg, Karen D.
    MICROORGANISMS, 2022, 10 (02)
  • [40] ACTIVITY AND VIABILITY FOLLOWING AEROLIZATION OF PSEUDOMONAS AERUGINOSA BACTERIOPHAGE AGAINST CLINICAL ISOLATES FROM CYSTIC FIBROSIS PATIENTS
    Enright, M. C.
    PEDIATRIC PULMONOLOGY, 2010, : 311 - 312